Hybrid magnetic resonance contrast agents

Details Hybrid magnetic resonance contrast agents Hybrid magnetic resonance contrast agents

1994-02-28

1995-04-18

Acquah, Samuel A.

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

Magnetic imaging agent

528272, 528274, 528275, 528277, 528278, 528280, 528289, 528290, 528293, 528295, 528296, 528298, 528299, 528300, 528302, 528307, 528308, 528332, 528335, 528342, 528350, 528354, 525437, 525443, 525444, 1286532, 1286534, 436173, 436806, 600 12, A61K 4900, A61B 600, C08F 2000

Patent

active

054076579

ABSTRACT:
Novel MRI contrast agents that comprise one or more metal-ion chelates in juxtaposition with one or more free-radical nitroxide compounds in a polymeric or oligomeric molecule. Both the chelate units and the free radical units may, independently, be inside the main chain of the polymer or in a side chain of the linkage portion of the polymer. The number of combined units of chelates and free radicals in the polymer or oligomer is at least two.

REFERENCES:
patent: 4822594 (1989-04-01), Gibby
patent: 4834964 (1989-05-01), Rosen
patent: 4863717 (1989-09-01), Keana
patent: 4933441 (1990-06-01), Gibby
patent: 5104641 (1992-04-01), Rosen
patent: 5135737 (1992-08-01), Keana

Affiliated with

Also associated with

Rating

Hybrid magnetic resonance contrast agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hybrid magnetic resonance contrast agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid magnetic resonance contrast agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-65119